Inventor
TAKENAKA SHUNSUKE
US3 patents
Patents
3 patentsUS11541103B2Jan 3, 2023
Interleukin-21 mutein/ anti-PD-1 antibody conjugates
AMGEN INC7 citations82
US11518808B2Dec 6, 2022
Anti-PD-1 antibodies and methods of treatment
AMGEN INC5 citations68
US11926672B2Mar 12, 2024
Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors
AMGEN INC0 citations39